 By M. Marin NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT Milestone: more than 100,000 CytoSorb cartridges delivered globally Cytosorbents NASDAQ:CTSO reported 2Q20 revenue of 9.8 million this week, up 58 yy and a quarterly record. Of this, 9.5 million was product revenue, which we believe underscores growing demand for CytoSorb as the company continues to generate data supporting its 